MMJ International Holdings says the DEA marijuana rescheduling hearing is drawing arguments for and against rescheduling, while it highlights publicly disclosed political spending by major state-licensed cannabis companies and a federal cultivation application that has been unresolved since 2018. The tone is cautious/uncertain given the unresolved regulatory and administrative backdrop.
MMJ International Holdings says the DEA marijuana rescheduling hearing is drawing arguments for and against rescheduling, while it highlights publicly disclosed political spending by major state-licensed cannabis companies and a federal cultivation application that has been unresolved since 2018. The tone is cautious/uncertain given the unresolved regulatory and administrative backdrop.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
